Biased regulation of glucocorticoid receptors signaling.
AL438 (PubChem CID: 9906282)
AZD9567 (PubChem CID: 121248172)
BI653048 (PubChem CID: 44543970)
Biased regulation
C108297 (PubChem CID: 25110774)
CpdA (PubChem CID: 9838148)
Fosdagrocorat (PubChem CID: 24872952)
GSK866 (PubChem CID: 25058139)
GW870086 (PubChem CID: 11376392)
Glucocorticoid receptor
LEO 134310 (PubChem CID: 126714060)
ORG 214007–0 (PubChem CID: 154659439)
RU24782 (PubChem CID: 385448896)
RU24858 (PubChem CID: 223258861)
Selective glucocorticoid receptor agonists
Selective glucocorticoid receptor modulators
ZK216348 (PubChem CID: 9805004)
ZK245186 (PubChem CID: 24795088)
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
11
05
2023
revised:
03
07
2023
accepted:
07
07
2023
medline:
17
8
2023
pubmed:
17
7
2023
entrez:
16
7
2023
Statut:
ppublish
Résumé
Glucocorticoids (GCs), steroid hormones that depend on glucocorticoid receptor (GR) binding for their action, are essential for regulating numerous homeostatic functions in the body.GR signals are biased, that is, GR signals are various in different tissue cells, disease states and ligands. This biased regulation of GR signaling appears to depend on ligand-induced metameric regulation, protein post-translational modifications, assembly at response elements, context-specific assembly (recruitment of co-regulators) and intercellular differences. Based on the bias regulation of GR, selective GR agonists and modulators (SEGRAMs) were developed to bias therapeutic outcomes toward expected outcomes (e.g., anti-inflammation and immunoregulation) by influencing GR-mediated gene expression. This paper provides a review of the bias regulation and mechanism of GR and the research progress of drugs.
Identifiants
pubmed: 37454592
pii: S0753-3322(23)00936-8
doi: 10.1016/j.biopha.2023.115145
pii:
doi:
Substances chimiques
Receptors, Glucocorticoid
0
Glucocorticoids
0
Anti-Inflammatory Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
115145Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest I declare that this article does not involve any conflict of interest.